Literature DB >> 20418193

Novel isoform of the Xenopus tropicalis PKA catalytic alpha subunit: An example of alternative splicing.

Mohammad Tabish1, Vladimir I Rodionov.   

Abstract

The cAMP-dependent protein kinase (PKA) plays key roles in the control of various aspects of eukaryotic cellular activities by phosphorylating several proteins and is multifunctional in nature. In the case of frog, Xenopus tropicalis, a gene encoding the PKA catalytic alpha subunit has been identified which encodes a single protein. Here we report the occurrence of N-terminal alternative splicing events in X. tropicalis tadpole that, in addition to generating a myristoylatable isoforms, also generate the non-myristoylated variant of the catalytic alpha subunit as has been reported in various other organisms. In addition to the already characterized exon 1, the 5' untranslated region and first intron actually contains one more other exon, that is alternatively spliced on to exon 2 at the 5' end of the pre-mRNA. This N-terminal alternative splicing occurs in combination with already characterized all internal exons. Thus, X. tropicalis tadpole expresses at least two different isoforms of the catalytic alpha subunit of PKA. The significance of this structural diversity in the family of PKA catalytic subunits is discussed. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20418193      PMCID: PMC2875305          DOI: 10.1016/j.cbd.2010.03.006

Source DB:  PubMed          Journal:  Comp Biochem Physiol Part D Genomics Proteomics        ISSN: 1744-117X            Impact factor:   2.674


  32 in total

1.  Genome-wide detection of alternative splicing in expressed sequences of human genes.

Authors:  B Modrek; A Resch; C Grasso; C Lee
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

2.  Cloning, sequence, and expression of the Drosophila cAMP-dependent protein kinase catalytic subunit gene.

Authors:  J L Foster; G C Higgins; F R Jackson
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

3.  Comparison of morpholino based translational inhibition during the development of Xenopus laevis and Xenopus tropicalis.

Authors:  S L Nutt; O J Bronchain; K O Hartley; E Amaya
Journal:  Genesis       Date:  2001-07       Impact factor: 2.487

4.  Drosophila Dscam is an axon guidance receptor exhibiting extraordinary molecular diversity.

Authors:  D Schmucker; J C Clemens; H Shu; C A Worby; J Xiao; M Muda; J E Dixon; S L Zipursky
Journal:  Cell       Date:  2000-06-09       Impact factor: 41.582

5.  Techniques and probes for the study of Xenopus tropicalis development.

Authors:  Mustafa K Khokha; Christina Chung; Erika L Bustamante; Lisa W K Gaw; Kristin A Trott; Joanna Yeh; Nancy Lim; Jennifer C Y Lin; Nicola Taverner; Enrique Amaya; Nancy Papalopulu; James C Smith; Aaron M Zorn; Richard M Harland; Timothy C Grammer
Journal:  Dev Dyn       Date:  2002-12       Impact factor: 3.780

6.  Genetic and genomic tools for Xenopus research: The NIH Xenopus initiative.

Authors:  Steven L Klein; Robert L Strausberg; Lukas Wagner; Joan Pontius; Sandra W Clifton; Paul Richardson
Journal:  Dev Dyn       Date:  2002-12       Impact factor: 3.780

7.  Developmentally induced, muscle-specific trans factors control the differential splicing of alternative and constitutive troponin T exons.

Authors:  R E Breitbart; B Nadal-Ginard
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

8.  Cloning, characterization, and expression of the gene for the catalytic subunit of cAMP-dependent protein kinase in Caenorhabditis elegans. Identification of highly conserved and unique isoforms generated by alternative splicing.

Authors:  R E Gross; S Bagchi; X Lu; C S Rubin
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.

Authors:  Yee Sook Cho; Yoon S Cho-Chung
Journal:  Clin Cancer Res       Date:  2003-03       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.